Sleep apneas and cardiovascular risk after Sleep Apnea Cardiovascular Endpoints Study (SAVE). What next?
Arch Bronconeumol (Engl Ed). 2018 May;54(5):241-242.
doi: 10.1016/j.arbres.2017.06.005.
Epub 2017 Jul 17.
[Article in
English,
Spanish]
Affiliations
- 1 Hospital Universitario de Guadalajara, Guadalajara, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España. Electronic address: olgamediano@hotmail.com.
- 2 Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
- 3 Adelaide Institute for Sleep Health, South Australia, Australia.
- 4 Hospital Universitari Arnau de Vilanova y Santa Maria, IRB Lleida, Lleida, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España.
No abstract available
MeSH terms
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Causality
-
Continuous Positive Airway Pressure*
-
Disorders of Excessive Somnolence / prevention & control
-
Humans
-
Multicenter Studies as Topic
-
Quality of Life
-
Randomized Controlled Trials as Topic
-
Research Design
-
Risk Factors
-
Secondary Prevention
-
Sleep Apnea Syndromes / complications
-
Sleep Apnea Syndromes / epidemiology
-
Sleep Apnea Syndromes / psychology
-
Sleep Apnea Syndromes / therapy*
-
Treatment Outcome